KR930702016A - 골다공증 치료제 - Google Patents

골다공증 치료제

Info

Publication number
KR930702016A
KR930702016A KR1019930700665A KR930700665A KR930702016A KR 930702016 A KR930702016 A KR 930702016A KR 1019930700665 A KR1019930700665 A KR 1019930700665A KR 930700665 A KR930700665 A KR 930700665A KR 930702016 A KR930702016 A KR 930702016A
Authority
KR
South Korea
Prior art keywords
osteoporosis
colony stimulating
macrophage colony
side effects
bone formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930700665A
Other languages
English (en)
Korean (ko)
Inventor
다쿠지 하나무라
양자 이
야스시 마쓰오카
마사노리 스기우라
Original Assignee
스야마 다다가즈
가부시키가이샤미도리쥬지
오노 아키라
모리나가뉴교가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스야마 다다가즈, 가부시키가이샤미도리쥬지, 오노 아키라, 모리나가뉴교가부시키가이샤 filed Critical 스야마 다다가즈
Publication of KR930702016A publication Critical patent/KR930702016A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019930700665A 1991-07-08 1992-07-07 골다공증 치료제 Withdrawn KR930702016A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP91-192714 1991-07-08
JP3192714A JPH0517367A (ja) 1991-07-08 1991-07-08 骨粗鬆症治療剤
PCT/JP1992/000874 WO1993000921A1 (en) 1991-07-08 1992-07-07 Remedy for osteoporosis

Publications (1)

Publication Number Publication Date
KR930702016A true KR930702016A (ko) 1993-09-08

Family

ID=16295841

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700665A Withdrawn KR930702016A (ko) 1991-07-08 1992-07-07 골다공증 치료제

Country Status (5)

Country Link
EP (1) EP0547234A1 (enExample)
JP (1) JPH0517367A (enExample)
KR (1) KR930702016A (enExample)
CA (1) CA2090453A1 (enExample)
WO (1) WO1993000921A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100484569C (zh) * 2001-11-19 2009-05-06 协和发酵工业株式会社 将多潜能干细胞从组织中流通到外周血的药物
HUE026132T2 (en) 2004-01-07 2016-05-30 Novartis Vaccines & Diagnostics Inc M-CSF-specific monoclonal antibody and its uses
US8470977B2 (en) 2008-03-14 2013-06-25 Transgene S.A. Antibody against the CSF-1R
BRPI0909044B8 (pt) * 2008-03-14 2021-05-25 Transgene Sa anticorpo que se liga especificamente ao csf-1r humano,composição farmacêutica e uso dos mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638204B2 (en) * 1987-11-12 1993-06-24 Schering Corporation Acceleration of bone formation with gm-csf
JPH022391A (ja) * 1988-02-08 1990-01-08 Otsuka Pharmaceut Co Ltd ヒトｍ―ｃｓｆ及びその製造法
DE69022606T2 (de) * 1989-02-28 1996-05-02 Morinaga Milk Industry Co Ltd Menschlichen Monozyt-Makrophagen-Koloniestimulierungsfaktor enthaltende Zusammensetzung.

Also Published As

Publication number Publication date
WO1993000921A1 (en) 1993-01-21
JPH0517367A (ja) 1993-01-26
EP0547234A1 (en) 1993-06-23
EP0547234A4 (enExample) 1994-02-09
CA2090453A1 (en) 1993-01-09

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DE3374300D1 (en) Stabilized activated oxygen and medicaments containing this stabilized activated oxygen
DE69535684D1 (de) Zusammensetzungen welche DNA zerstoerende Agentien und P53 enthalten
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
BRPI0414568A (pt) combinações de drogas para o tratamento de neoplasmas
DE69332758D1 (de) Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
ES2184145T3 (es) Compuestos de acido sulfonico o sulfonilamino-n-(heteroaralquil)-azaheterociclilamida.
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
KR930702016A (ko) 골다공증 치료제
KR930019224A (ko) 유산 위험 치료제
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
KR900017599A (ko) 종양 치료용 약학 조성물
ES2176218T3 (es) Agente carcinostatico para terapia hormonal que contiene dienogesto como componente activo.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ES2058161T3 (es) Producto activo para la lucha contra tumores.
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE223212T1 (de) Conagenine zur prävention und behandlung von diarrhöe
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930305

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid